Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 375 of 3033 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 06/02/22
Due: 06/02/23
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 05/18/22
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 12/02/24
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 07/25/17
Due: 07/25/18
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 04/30/06
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/24/24
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 05/30/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/19/23
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 09/04/18
End: 03/01/20
Due: 03/01/21
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 12/31/05
Due: 12/31/06
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 07/15/24
Due: 07/15/25
Phase: N/A
Priority: Normal
Start: 11/15/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 08/15/20
Due: 08/15/21
Phase: N/A
Priority: Normal
Start: 11/02/20
End: 04/07/22
Due: 04/07/23
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 07/24/18
End: 04/10/21
Due: 04/10/22